Ethris is Drug Discovery in Germany that focus on RNA-modification technology business. Founded in 2009. They cover business area such as developer, RNA-base therapy, patient, respiratory disorder, stable and non-immunogenic messenger RNA, SNIM-RNA) molecule, use, protein-replacement therapy, healthcare provider, monogenic genetic disease, personalize vaccine, tumor.
2009
( 15 years old in 2024 )
RNA-modification Technology
-
Semmelweisstr. 3
82152 Planegg
Germany
Private
developerRNA-base therapypatientrespiratory disorderstable and non-immunogenic messenger RNASNIM-RNA) moleculeuseprotein-replacement therapyhealthcare providermonogenic genetic diseasepersonalize vaccinetumor
* We use standard office opening hours in near Ethris's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ethris is Drug Discovery business from Germany that founded in 2009 (15 years old in 2024), Ethris business is focusing on RNA-modification Technology.
Ethris headquarter office and corporate office address is located in Semmelweisstr. 3 82152 Planegg Germany.
Ethris was founded in Germany.
In 2024, Ethris is currently focus on RNA-modification technology sector.
Above is snippet of Google Trends for "RNA-modification technology" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ethris, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
